OK-432 sclerotherapy in head and neck lymphangiomas: Long-term follow-up result

INTRODUCTION: Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy. MATERIALS AND METHODS: Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected. RESULTS: Initial response rates were 83.5 percent and long-term response rates were 76.3 percent. CONCLUSION: initial and the long-term response rate were equally good for lymphangioma. (C) 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.Okazaki T, 2007, J PEDIATR SURG, V42, P386, DOI 10.1016/j.jpedsurg.2006.10.012Luzzatto C, 2005, PEDIATR SURG INT, V21, P969, DOI 10.1007/s00383-005-1564-9Kim KH, 2004, OTOLARYNG HEAD NECK, V131, P307, DOI 10.1016/j.otohns.2004.02.018Claesson G, 2002, INT J PEDIATR OTORHI, V65, P1Sung MW, 2001, LARYNGOSCOPE, V111, P1430Orvidas LJ, 2000, ANN OTO RHINOL LARYN, V109, P411Greinwald JH, 1999, OTOLARYNG HEAD NECK, V121, P381MCGILL TJI, 1998, OTOLARYNGOLOGY HEAD, P66Hase T, 1996, EUR J PEDIATR, V155, P424DESERRES LM, 1995, ARCH OTOLARYNGOL, V121, P577OGITA SH, 1994, J PEDIATR SURG, V29, P7841